RAMM Pharma Corp. (CSE:RAMM)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Jul 20, 2026, 5:41 PM EST

RAMM Pharma Statistics

Total Valuation

RAMM Pharma has a market cap or net worth of CAD 1.19 million. The enterprise value is 1.12 million.

Market Cap1.19M
Enterprise Value 1.12M

Important Dates

The next estimated earnings date is Friday, September 25, 2026.

Earnings Date Sep 25, 2026
Ex-Dividend Date n/a

Share Statistics

RAMM Pharma has 119.39 million shares outstanding.

Current Share Class 119.39M
Shares Outstanding 119.39M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 31.43%
Owned by Institutions (%) 0.01%
Float 81.87M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.63
PB Ratio 0.27
P/TBV Ratio 0.27
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.01.

Current Ratio 0.47
Quick Ratio 0.20
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.76

Financial Efficiency

Return on equity (ROE) is -102.05% and return on invested capital (ROIC) is -30.80%.

Return on Equity (ROE) -102.05%
Return on Assets (ROA) -23.31%
Return on Invested Capital (ROIC) -30.80%
Return on Capital Employed (ROCE) -97.33%
Weighted Average Cost of Capital (WACC) 22.43%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.17
Inventory Turnover 0.86

Taxes

In the past 12 months, RAMM Pharma has paid 10,699 in taxes.

Income Tax 10,699
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.59
52-Week Price Change n/a
50-Day Moving Average 0.03
200-Day Moving Average 0.03
Relative Strength Index (RSI) 39.99
Average Volume (20 Days) 85,297

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RAMM Pharma had revenue of CAD 1.89 million and -8.72 million in losses. Loss per share was -0.07.

Revenue1.89M
Gross Profit 736,608
Operating Income -4.23M
Pretax Income -8.70M
Net Income -8.72M
EBITDA -3.90M
EBIT -4.23M
Loss Per Share -0.07
Full Income Statement

Balance Sheet

The company has 119,546 in cash and 44,171 in debt, with a net cash position of 75,375 or 0.00 per share.

Cash & Cash Equivalents 119,546
Total Debt 44,171
Net Cash 75,375
Net Cash Per Share 0.00
Equity (Book Value) 4.35M
Book Value Per Share 0.04
Working Capital -1.46M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.60M
Capital Expenditures n/a
Depreciation & Amortization 328,597
Net Borrowing -69,800
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 38.93%
Operating Margin -223.55%
Pretax Margin -460.07%
Profit Margin n/a
EBITDA Margin -206.18%
EBIT Margin -223.55%
FCF Margin n/a

Dividends & Yields

RAMM Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -730.02%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RAMM Pharma has an Altman Z-Score of -16.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.07
Piotroski F-Score 2